nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—blood plasma—acquired immunodeficiency syndrome	0.0219	0.107	CbGeAlD
Fluocinolone Acetonide—SERPINA6—blood plasma—acquired immunodeficiency syndrome	0.0218	0.106	CbGeAlD
Fluocinolone Acetonide—NR3C1—nerve—acquired immunodeficiency syndrome	0.0127	0.0615	CbGeAlD
Fluocinolone Acetonide—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.00957	0.0465	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—blood—acquired immunodeficiency syndrome	0.00804	0.0391	CbGeAlD
Fluocinolone Acetonide—SERPINA6—blood—acquired immunodeficiency syndrome	0.008	0.0389	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—bone marrow—acquired immunodeficiency syndrome	0.00778	0.0378	CbGeAlD
Fluocinolone Acetonide—SERPINA6—bone marrow—acquired immunodeficiency syndrome	0.00774	0.0377	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—spinal cord—acquired immunodeficiency syndrome	0.00774	0.0377	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—vagina—acquired immunodeficiency syndrome	0.00745	0.0362	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lung—acquired immunodeficiency syndrome	0.00705	0.0343	CbGeAlD
Fluocinolone Acetonide—SERPINA6—lung—acquired immunodeficiency syndrome	0.00702	0.0341	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—nervous system—acquired immunodeficiency syndrome	0.00652	0.0317	CbGeAlD
Fluocinolone Acetonide—SERPINA6—nervous system—acquired immunodeficiency syndrome	0.0065	0.0316	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—central nervous system—acquired immunodeficiency syndrome	0.00628	0.0306	CbGeAlD
Fluocinolone Acetonide—SERPINA6—central nervous system—acquired immunodeficiency syndrome	0.00626	0.0304	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—brain—acquired immunodeficiency syndrome	0.00499	0.0243	CbGeAlD
Fluocinolone Acetonide—SERPINA6—brain—acquired immunodeficiency syndrome	0.00497	0.0242	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lymph node—acquired immunodeficiency syndrome	0.00482	0.0234	CbGeAlD
Fluocinolone Acetonide—NR3C1—skin of body—acquired immunodeficiency syndrome	0.0046	0.0224	CbGeAlD
Fluocinolone Acetonide—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.00373	0.0181	CbGeAlD
Fluocinolone Acetonide—NR3C1—digestive system—acquired immunodeficiency syndrome	0.00368	0.0179	CbGeAlD
Fluocinolone Acetonide—NR3C1—blood—acquired immunodeficiency syndrome	0.00351	0.017	CbGeAlD
Fluocinolone Acetonide—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.00339	0.0165	CbGeAlD
Fluocinolone Acetonide—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.00338	0.0164	CbGeAlD
Fluocinolone Acetonide—NR3C1—vagina—acquired immunodeficiency syndrome	0.00325	0.0158	CbGeAlD
Fluocinolone Acetonide—NR3C1—lung—acquired immunodeficiency syndrome	0.00307	0.0149	CbGeAlD
Fluocinolone Acetonide—NR3C1—nervous system—acquired immunodeficiency syndrome	0.00285	0.0138	CbGeAlD
Fluocinolone Acetonide—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.00274	0.0133	CbGeAlD
Fluocinolone Acetonide—NR3C1—brain—acquired immunodeficiency syndrome	0.00218	0.0106	CbGeAlD
Fluocinolone Acetonide—NR3C1—lymph node—acquired immunodeficiency syndrome	0.0021	0.0102	CbGeAlD
Fluocinolone Acetonide—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.00162	0.00204	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00204	CcSEcCtD
Fluocinolone Acetonide—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00161	0.00203	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.00201	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00159	0.00201	CcSEcCtD
Fluocinolone Acetonide—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00159	0.002	CcSEcCtD
Fluocinolone Acetonide—Pain—Didanosine—acquired immunodeficiency syndrome	0.00159	0.002	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00158	0.00199	CcSEcCtD
Fluocinolone Acetonide—Infection—Abacavir—acquired immunodeficiency syndrome	0.00158	0.00198	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00156	0.00196	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00196	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00155	0.00196	CcSEcCtD
Fluocinolone Acetonide—Back pain—Indinavir—acquired immunodeficiency syndrome	0.00154	0.00194	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00194	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.00154	0.00194	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00193	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.00153	0.00192	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00152	0.00191	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.0019	CcSEcCtD
Fluocinolone Acetonide—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.0019	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00189	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00189	CcSEcCtD
Fluocinolone Acetonide—Cough—Zidovudine—acquired immunodeficiency syndrome	0.0015	0.00188	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.00148	0.00186	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00186	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00147	0.00186	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00147	0.00185	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.00147	0.00185	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00147	0.00185	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00147	0.00184	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.00146	0.00184	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.00146	0.00184	CcSEcCtD
Fluocinolone Acetonide—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.00146	0.00183	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00182	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00144	0.00182	CcSEcCtD
Fluocinolone Acetonide—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00181	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00181	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00144	0.00181	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00144	0.00181	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00143	0.0018	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.0018	CcSEcCtD
Fluocinolone Acetonide—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00143	0.00179	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00179	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00179	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.00178	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00177	CcSEcCtD
Fluocinolone Acetonide—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.0014	0.00176	CcSEcCtD
Fluocinolone Acetonide—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00175	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00139	0.00175	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00139	0.00175	CcSEcCtD
Fluocinolone Acetonide—Cough—Indinavir—acquired immunodeficiency syndrome	0.00139	0.00175	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00139	0.00175	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00174	CcSEcCtD
Fluocinolone Acetonide—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00174	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00174	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00173	CcSEcCtD
Fluocinolone Acetonide—Pain—Stavudine—acquired immunodeficiency syndrome	0.00138	0.00173	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00173	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00137	0.00172	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00137	0.00172	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00171	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00136	0.00171	CcSEcCtD
Fluocinolone Acetonide—Pain—Abacavir—acquired immunodeficiency syndrome	0.00136	0.00171	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.0017	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00169	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00168	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00167	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00132	0.00166	CcSEcCtD
Fluocinolone Acetonide—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00131	0.00165	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00131	0.00165	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00164	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.0013	0.00164	CcSEcCtD
Fluocinolone Acetonide—Oedema—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00164	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00129	0.00163	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00129	0.00163	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.00162	CcSEcCtD
Fluocinolone Acetonide—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.00162	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00161	CcSEcCtD
Fluocinolone Acetonide—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00161	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00128	0.00161	CcSEcCtD
Fluocinolone Acetonide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00128	0.00161	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00128	0.00161	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00128	0.00161	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00161	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00127	0.0016	CcSEcCtD
Fluocinolone Acetonide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00127	0.0016	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00127	0.0016	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00127	0.0016	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00159	CcSEcCtD
Fluocinolone Acetonide—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00158	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00158	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00158	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00158	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.00156	CcSEcCtD
Fluocinolone Acetonide—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00156	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00123	0.00155	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00123	0.00154	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00154	CcSEcCtD
Fluocinolone Acetonide—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00154	CcSEcCtD
Fluocinolone Acetonide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00121	0.00152	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00121	0.00152	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00152	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00151	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00151	CcSEcCtD
Fluocinolone Acetonide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.00151	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00119	0.0015	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00119	0.00149	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00119	0.00149	CcSEcCtD
Fluocinolone Acetonide—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00149	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00148	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00118	0.00148	CcSEcCtD
Fluocinolone Acetonide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00148	CcSEcCtD
Fluocinolone Acetonide—Rash—Didanosine—acquired immunodeficiency syndrome	0.00117	0.00147	CcSEcCtD
Fluocinolone Acetonide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00147	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00117	0.00147	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00117	0.00147	CcSEcCtD
Fluocinolone Acetonide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00146	CcSEcCtD
Fluocinolone Acetonide—Headache—Didanosine—acquired immunodeficiency syndrome	0.00116	0.00146	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00145	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.00144	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00114	0.00144	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00143	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00113	0.00143	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00112	0.00141	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00112	0.00141	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00141	CcSEcCtD
Fluocinolone Acetonide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00141	CcSEcCtD
Fluocinolone Acetonide—Pain—Indinavir—acquired immunodeficiency syndrome	0.00111	0.0014	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.00139	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.00139	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.0011	0.00139	CcSEcCtD
Fluocinolone Acetonide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0011	0.00139	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00138	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00137	CcSEcCtD
Fluocinolone Acetonide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00137	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00137	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.00135	CcSEcCtD
Fluocinolone Acetonide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00134	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00107	0.00134	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00134	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00106	0.00134	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00106	0.00134	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00106	0.00133	CcSEcCtD
Fluocinolone Acetonide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00132	CcSEcCtD
Fluocinolone Acetonide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00105	0.00132	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00105	0.00132	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00105	0.00132	CcSEcCtD
Fluocinolone Acetonide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00132	CcSEcCtD
Fluocinolone Acetonide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00104	0.00131	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00131	CcSEcCtD
Fluocinolone Acetonide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00131	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00103	0.00129	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00129	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00103	0.00129	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00102	0.00129	CcSEcCtD
Fluocinolone Acetonide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00102	0.00128	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00102	0.00128	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00128	CcSEcCtD
Fluocinolone Acetonide—Rash—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00128	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00128	CcSEcCtD
Fluocinolone Acetonide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00127	CcSEcCtD
Fluocinolone Acetonide—Headache—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00127	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00101	0.00127	CcSEcCtD
Fluocinolone Acetonide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00127	CcSEcCtD
Fluocinolone Acetonide—Rash—Abacavir—acquired immunodeficiency syndrome	0.001	0.00126	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000999	0.00126	CcSEcCtD
Fluocinolone Acetonide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000999	0.00126	CcSEcCtD
Fluocinolone Acetonide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000993	0.00125	CcSEcCtD
Fluocinolone Acetonide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000992	0.00125	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000991	0.00125	CcSEcCtD
Fluocinolone Acetonide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00099	0.00125	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00099	0.00125	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000979	0.00123	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000972	0.00122	CcSEcCtD
Fluocinolone Acetonide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000959	0.00121	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000958	0.00121	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000957	0.0012	CcSEcCtD
Fluocinolone Acetonide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000956	0.0012	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000954	0.0012	CcSEcCtD
Fluocinolone Acetonide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000942	0.00119	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000939	0.00118	CcSEcCtD
Fluocinolone Acetonide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00093	0.00117	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00093	0.00117	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000925	0.00116	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00092	0.00116	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00091	0.00115	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000906	0.00114	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000904	0.00114	CcSEcCtD
Fluocinolone Acetonide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000895	0.00113	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00089	0.00112	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000889	0.00112	CcSEcCtD
Fluocinolone Acetonide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000882	0.00111	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000881	0.00111	CcSEcCtD
Fluocinolone Acetonide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000876	0.0011	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00087	0.00109	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000866	0.00109	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000862	0.00109	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00086	0.00108	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00086	0.00108	CcSEcCtD
Fluocinolone Acetonide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000854	0.00107	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000841	0.00106	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000832	0.00105	CcSEcCtD
Fluocinolone Acetonide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000831	0.00105	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000827	0.00104	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000827	0.00104	CcSEcCtD
Fluocinolone Acetonide—Rash—Indinavir—acquired immunodeficiency syndrome	0.00082	0.00103	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000819	0.00103	CcSEcCtD
Fluocinolone Acetonide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000815	0.00103	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000813	0.00102	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000805	0.00101	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000801	0.00101	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000789	0.000994	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000781	0.000984	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000778	0.000979	CcSEcCtD
Fluocinolone Acetonide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000775	0.000976	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000774	0.000975	CcSEcCtD
Fluocinolone Acetonide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000773	0.000973	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000771	0.000971	CcSEcCtD
Fluocinolone Acetonide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00077	0.000969	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000769	0.000969	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000748	0.000941	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000744	0.000937	CcSEcCtD
Fluocinolone Acetonide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000741	0.000933	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000741	0.000933	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000741	0.000932	CcSEcCtD
Fluocinolone Acetonide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000737	0.000927	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000736	0.000926	CcSEcCtD
Fluocinolone Acetonide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00073	0.000919	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000719	0.000905	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000716	0.000902	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000706	0.000889	CcSEcCtD
Fluocinolone Acetonide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000699	0.000879	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000692	0.000871	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000691	0.00087	CcSEcCtD
Fluocinolone Acetonide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000686	0.000863	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000685	0.000862	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000683	0.00086	CcSEcCtD
Fluocinolone Acetonide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000681	0.000858	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000666	0.000838	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00066	0.000831	CcSEcCtD
Fluocinolone Acetonide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00066	0.000831	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000659	0.00083	CcSEcCtD
Fluocinolone Acetonide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000656	0.000825	CcSEcCtD
Fluocinolone Acetonide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000646	0.000813	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000635	0.000799	CcSEcCtD
Fluocinolone Acetonide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00063	0.000793	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000629	0.000792	CcSEcCtD
Fluocinolone Acetonide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000626	0.000787	CcSEcCtD
Fluocinolone Acetonide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000622	0.000783	CcSEcCtD
Fluocinolone Acetonide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000593	0.000747	CcSEcCtD
